jRCTs011230006Recruiting
Untitled Trial
Effect of initial treatment with tofogliflozin or metformin on pancreatic beta cell function in subjects with drug naive type 2 diabetes A multicenter, prospective, open label, parallel group, randomized, comparative study
Japan Registry Clinical Trial
VerifiedJapan Registry Clinical Trial
Study focus
- Disease/Condition
- Type 2 diabetes
- Study type
- Interventional
Sponsor & location
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus with multiple complications
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCTs011230006
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCTs011230006 through Pure Global AI's free database. This phase not specified trial is sponsored by sponsor not specified and is currently Recruiting. The study focuses on Type 2 diabetes.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.